
The new centre will be home to nearly 2,000 world-class researchers and scientists

This builds on a recently announced clinical collaboration between AstraZeneca and Summit to advance cancer treatments

Tulisokibart was designed to help address immuno-fibrosis, a key driver of disease progression in HS

The results from a global phase 3 trial show the longest survival data ever reported in this setting

This is the first new regimen in more than a decade for first-line treatment for this type of breast cancer

The mRNA-based therapy, used with Keytruda, is designed specifically for each patient

The treatments are for eligible adults in England and Wales

Asthma affects over 360 million people worldwide, including over 40 million people in Europe

The company will gain a novel oral treatment for lung cancer

Erleada plus hormone therapy significantly improved key short- and long-term clinical outcomes

COPD affects nearly 400 million people globally and is the third leading cause of death worldwide

This is the first and only perioperative immunotherapy approved to treat early gastric cancers